Goldman Sachs And 3 Other Stocks Insiders Are Selling

Although gold futures traded lower this morning on Friday, there were a few notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Enfusion

• The Trade: Enfusion, Inc. ENFN Director FTV IV, L.P. sold a total of 4,075,531 shares at an average price of $15.90. The insider received around $64.78 million from selling those shares.
• What’s Happening: Enfusion, last month, reported Q4 earnings results and issued Q1 and FY22 guidance.
• What Enfusion Does: Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry.

Airbnb

• The Trade: Airbnb, Inc. ABNB Chief Financial Officer Dave Stephenson sold a total of 35,000 shares at an average price of $177.81. The insider received around $6.22 million from selling those shares.
• What’s Happening: Citigroup recently upgraded Airbnb from Neutral to Buy and lowered the price target from $214 to $200.
• What Airbnb Does: Started in 2008, Airbnb is the world's largest online alternative accommodation travel agency, also offering booking services for boutique hotels and experiences.

Also check this: 2 Stocks Under $5 Insiders Are Aggressively Buying

Goldman Sachs

• The Trade: The Goldman Sachs Group, Inc. GS Director, Chairman of the Board and CEO David Solomon sold a total of 9,768 shares at an average price of $334.57. The insider received around $3.27 million as a result of the transaction.
• What’s Happening: Goldman Sachs recently reported better-than-expected Q1 EPS and sales results.
• What Goldman Sachs Does: Goldman Sachs is a leading global investment banking firm whose activities are organized into investment banking (20% of net revenue), global markets (45%), asset management (20%), and consumer and wealth management (15%) segments.

Have a look at our premarket coverage here .

Boston Scientific

• The Trade: Boston Scientific Corporation BSX EVP & Pres, Periph Intervent Jeffrey Mirviss sold a total of 9,645 shares at an average price of $46.50. The insider received around $448.49 thousand from selling those shares.
• What’s Happening: The company is scheduled to release its quarterly earnings on April 27, 2022.
• What Boston Scientific Does: Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts.